Platelet-inhibitor drugs' role in coronary artery disease.
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D013442:Sulfinpyrazone / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone